Pulmatrix, Inc.
US ˙ NasdaqCM ˙ US74584P3010

Introduction

This page provides a comprehensive analysis of the known insider trading history of Roach James M.. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Roach James M. has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:PULM / Pulmatrix, Inc. Chief Medical Officer 801,000
Senior VP, Development and Chi 155,381
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Roach James M.. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases PULM / Pulmatrix, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in PULM / Pulmatrix, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

PULM / Pulmatrix, Inc. Insider Trades
Insider Sales PULM / Pulmatrix, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in PULM / Pulmatrix, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

PULM / Pulmatrix, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Roach James M. as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2018-06-06 2018-06-05 4 PULM Pulmatrix, Inc.
Stock Option (Right to Buy)
A - Award 801,000 801,000
2017-11-07 2017-11-03 4 PULM Pulmatrix, Inc.
Stock Option (Right to Buy)
A - Award 360,000 360,000
2016-11-23 2016-11-22 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -250 155,381 -0.16 14.40 -3,600 2,237,486
2016-11-23 2016-11-21 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -425 155,631 -0.27 13.45 -5,716 2,093,237
2016-11-23 2016-11-21 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -416 156,056 -0.27 13.45 -5,595 2,098,953
2016-08-23 2016-08-22 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -249 156,472 -0.16 12.10 -3,013 1,893,311
2016-08-23 2016-08-19 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -426 156,721 -0.27 12.04 -5,129 1,886,921
2016-08-23 2016-08-19 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -416 157,147 -0.26 12.04 -5,009 1,892,050
2016-05-23 2016-05-20 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -250 157,563 -0.16 10.11 -2,528 1,592,962
2016-05-23 2016-05-19 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -426 157,813 -0.27 10.20 -4,345 1,609,693
2016-05-23 2016-05-19 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -416 158,239 -0.26 10.20 -4,243 1,614,038
2016-04-19 2016-04-18 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
F - Taxes -6,206 158,655 -3.76 9.69 -60,136 1,537,367
2016-04-15 2016-04-13 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
A - Award 60,000 164,861 57.22
2016-02-24 2016-02-22 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -250 104,861 -0.24 9.65 -2,412 1,011,909
2016-02-22 2016-02-19 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -1,734 105,111 -1.62 9.64 -16,716 1,013,270
2016-02-22 2016-02-19 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -424 106,845 -0.40 9.65 -4,092 1,031,054
2016-02-19 2016-02-18 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -272 107,269 -0.25 10.49 -2,853 1,125,252
2016-02-11 2016-02-09 4 MNTA MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 34,200 34,200
2016-02-11 2016-02-09 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale 17,100 107,541 18.91
2015-11-23 2015-11-20 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -360 90,441 -0.40 17.75 -6,390 1,605,328
2015-11-20 2015-11-19 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -603 90,801 -0.66 18.17 -10,957 1,649,854
2015-11-18 2015-11-17 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -312 91,404 -0.34 17.65 -5,507 1,613,281
2015-08-24 2015-08-20 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -363 91,716 -0.39 22.20 -8,059 2,036,095
2015-08-20 2015-08-19 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -6,410 92,079 -6.51 22.10 -141,661 2,034,946
2015-08-20 2015-08-19 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -601 98,489 -0.61 22.00 -13,222 2,166,758
2015-08-19 2015-08-18 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -6,500 99,090 -6.16 21.81 -141,765 2,161,153
2015-08-19 2015-08-17 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -312 105,590 -0.29 21.67 -6,761 2,288,135
2015-06-19 2015-06-18 4 MNTA MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise X -25,000 47,500 -34.48
2015-06-19 2015-06-18 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -25,000 105,902 -19.10 23.70 -592,500 2,509,877
2015-06-19 2015-06-18 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
M - Exercise X 25,000 130,902 23.61 7.41 185,250 969,984
2015-06-02 2015-06-01 4 MNTA MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise X -25,000 72,500 -25.64
2015-06-02 2015-06-01 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -25,000 105,902 -19.10 21.70 -542,500 2,298,073
2015-06-02 2015-06-01 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
M - Exercise X 25,000 130,902 23.61 7.41 185,250 969,984
2015-05-21 2015-05-20 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -360 105,902 -0.34 19.68 -7,085 2,084,151
2015-05-20 2015-05-19 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -617 106,262 -0.58 19.63 -12,112 2,085,923
2015-05-19 2015-05-15 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -311 106,879 -0.29 19.96 -6,208 2,133,305
2015-04-20 2015-04-16 4 MNTA MOMENTA PHARMACEUTICALS INC
Option to purchase stock
M - Exercise X 50,000 97,500 105.26
2015-04-20 2015-04-16 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -50,000 107,190 -31.81 18.70 -935,000 2,004,453
2015-04-20 2015-04-16 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
F - Taxes -6,215 157,190 -3.80 17.08 -106,152 2,684,805
2015-04-20 2015-04-16 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
M - Exercise X 50,000 163,405 44.09 7.41 370,500 1,210,831
2015-04-20 2015-03-29 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -6,750 113,405 -5.62
2015-02-25 2015-02-24 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -192 120,155 -0.16 13.56 -2,604 1,629,302
2015-02-25 2015-02-23 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -199 120,347 -0.17 12.93 -2,573 1,556,087
2015-02-23 2015-02-20 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -249 120,546 -0.21 13.40 -3,337 1,615,316
2015-02-23 2015-02-19 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -1,664 120,795 -1.36 12.91 -21,482 1,559,463
2015-02-20 2015-02-18 4 MNTA MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 41,498 352,413 13.35 13.02 540,304 4,588,417
2015-02-20 2015-02-18 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -252 122,459 -0.21 11.91 -3,001 1,458,487
2015-02-20 2015-02-18 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
A - Award 20,748 122,711 20.35
2014-11-26 2014-11-25 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -192 101,963 -0.19 11.67 -2,241 1,189,908
2014-11-26 2014-11-24 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -199 102,155 -0.19 11.53 -2,294 1,177,847
2014-11-21 2014-11-20 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -250 102,354 -0.24 11.13 -2,782 1,139,200
2014-11-19 2014-11-17 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -217 102,604 -0.21 10.64 -2,309 1,091,707
2014-08-26 2014-08-25 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -192 102,821 -0.19 11.45 -2,198 1,177,300
2014-08-26 2014-08-22 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -199 103,013 -0.19 11.32 -2,253 1,166,107
2014-08-22 2014-08-20 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -250 103,212 -0.24 11.54 -2,885 1,191,066
2014-08-18 2014-08-15 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -217 103,462 -0.21 11.75 -2,550 1,215,678
2014-05-27 2014-05-23 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -192 103,679 -0.18 12.09 -2,321 1,253,479
2014-05-27 2014-05-22 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -199 103,871 -0.19 11.74 -2,336 1,219,446
2014-05-21 2014-05-20 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -250 104,070 -0.24 12.08 -3,020 1,257,166
2014-05-16 2014-05-15 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -217 104,320 -0.21 11.09 -2,407 1,156,909
2014-04-16 2014-04-15 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -485 104,537 -0.46 10.76 -5,219 1,124,818
2014-02-27 2014-02-25 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -192 105,022 -0.18 17.47 -3,354 1,834,734
2014-02-25 2014-02-21 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -995 105,214 -0.94 17.70 -17,612 1,862,288
2014-02-20 2014-02-19 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -197 106,209 -0.19 17.86 -3,518 1,896,893
2014-02-20 2014-02-18 4 MNTA MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 40,504 310,915 14.98
2014-02-20 2014-02-18 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
A - Award 20,278 106,406 23.54
2014-02-20 2014-02-18 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -217 86,128 -0.25 17.96 -3,897 1,546,859
2013-11-26 2013-11-25 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -192 86,345 -0.22 17.77 -3,412 1,534,351
2013-11-20 2013-11-19 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -197 86,537 -0.23 17.17 -3,382 1,485,840
2013-11-19 2013-11-15 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -217 86,734 -0.25 16.88 -3,663 1,464,070
2013-08-26 2013-08-23 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -192 86,951 -0.22 14.90 -2,861 1,295,570
2013-08-21 2013-08-20 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -197 87,143 -0.23 14.47 -2,851 1,260,959
2013-08-19 2013-08-15 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -218 87,340 -0.25 15.43 -3,364 1,347,656
2013-05-24 2013-05-23 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -195 87,558 -0.22 13.03 -2,541 1,140,881
2013-05-22 2013-05-21 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -197 87,753 -0.22 12.83 -2,528 1,125,871
2013-05-17 2013-05-15 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -217 87,950 -0.25 13.33 -2,893 1,172,374
2013-02-27 2013-02-26 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -192 88,167 -0.22 12.58 -2,415 1,109,141
2013-02-27 2013-02-25 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -189 88,359 -0.21 12.43 -2,349 1,098,302
2013-02-21 2013-02-20 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -188 88,548 -0.21 12.62 -2,373 1,117,476
2013-02-21 2013-02-19 4 MNTA MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 30,800 270,411 12.85
2013-02-21 2013-02-19 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
A - Award 12,100 88,736 15.79
2013-02-19 2013-02-15 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -838 76,636 -1.08 12.26 -10,274 939,557
2012-11-28 2012-11-27 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -192 77,474 -0.25 10.53 -2,022 815,801
2012-11-28 2012-11-26 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -188 77,666 -0.24 10.58 -1,989 821,706
2012-11-21 2012-11-20 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -193 77,854 -0.25 10.96 -2,115 853,280
2012-08-30 2012-08-28 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -192 78,047 -0.25 14.35 -2,755 1,119,974
2012-08-27 2012-08-23 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -187 78,239 -0.24 13.64 -2,551 1,067,180
2012-08-23 2012-08-21 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -193 78,426 -0.25 13.78 -2,660 1,080,710
2012-05-31 2012-05-29 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -192 78,619 -0.24 13.93 -2,675 1,095,163
2012-05-25 2012-05-23 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -189 78,811 -0.24 13.90 -2,627 1,095,473
2012-05-22 2012-05-21 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -192 79,000 -0.24 13.87 -2,663 1,095,730
2012-04-23 2012-04-19 4 MNTA MOMENTA PHARMACEUTICALS INC
Option to purchase stock
M - Exercise 15,000 239,611 6.68 7.41 111,150 1,775,518
2012-04-23 2012-04-19 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -15,000 79,192 -15.92 15.10 -226,500 1,195,799
2012-03-01 2012-02-28 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -191 79,192 -0.24 14.90 -2,846 1,179,961
2012-02-28 2012-02-24 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -708 79,383 -0.88 15.71 -11,123 1,247,107
2012-02-24 2012-02-22 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
S - Sale X -191 80,091 -0.24 15.11 -2,886 1,210,175
2012-02-16 2012-02-14 4 MNTA MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 26,183 254,611 11.46
2012-02-16 2012-02-14 4 MNTA MOMENTA PHARMACEUTICALS INC
Common Stock
A - Award 10,473 80,282 15.00
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)